Drug profile · INN
peginterferon beta-1a
PLEGRIDY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
peginterferon beta-1a (PLEGRIDY) is an FDA-listed pharmaceutical active ingredient. Associated with Biogen. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN peginterferon beta-1a
Brand PLEGRIDY
Route INJECTION
Formulation INJECTABLE
ATC code L03AB13
Originator Biogen
Frequently asked questions
What is peginterferon beta-1a?
peginterferon beta-1a (PLEGRIDY) is an FDA-listed pharmaceutical active ingredient. Associated with Biogen. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for peginterferon beta-1a?
PLEGRIDY is a marketed brand name for peginterferon beta-1a. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of peginterferon beta-1a?
peginterferon beta-1a has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.